Regencell Bioscience Lim... (RGC)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
4.86
0.05 (1.04%)
At close: Jan 14, 2025, 3:28 PM
4.86
0.00%
After-hours Jan 14, 2025, 03:28 PM EST
undefined% (undefined)
Bid | 4.8 |
Market Cap | 63.24M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -0.33 |
PE Ratio (ttm) | -14.73 |
Forward PE | n/a |
Analyst | n/a |
Ask | 5.19 |
Volume | 2,090 |
Avg. Volume (20D) | 96,798 |
Open | 4.99 |
Previous Close | 4.81 |
Day's Range | 4.86 - 5.05 |
52-Week Range | 3.03 - 32.44 |
Beta | undefined |
About RGC
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong....
2 months ago ·
Source
+31.18%
Regencell Bioscience shares are trading higher. Th...
Unlock content with
Pro Subscription